Landscape Capital Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,459
Closed -$433K 738
2025
Q4
$433K Sell
2,459
-4,663
-65% -$762K 0.03% 502
2025
Q3
$998K Buy
+7,122
New +$963K 0.06% 372
2025
Q2
Sell
-2,403
Closed -$329K 657
2025
Q1
$329K Buy
+2,403
New +$344K 0.03% 471
2019
Q4
Sell
-3,011
Closed -$701K 635
2019
Q3
$701K Buy
+3,011
New +$701K 0.05% 330
2018
Q4
Sell
-959
Closed -$339K 859
2018
Q3
$339K Sell
959
-1,470
-61% -$506K 0.03% 522
2018
Q2
$705K Buy
+2,429
New +$683K 0.06% 238
2017
Q4
Sell
-1,535
Closed -$481K 625
2017
Q3
$481K Buy
+1,535
New +$455K 0.05% 319

Other funds holding BIIB

Landscape Capital Management's BIIB Position: Q1 2026 in Review

Landscape Capital Management sold out of Biogen (BIIB) in Q1 2026, closing a stake of 2,459 shares — an estimated $433K sold.

Landscape Capital Management first reported a position in BIIB in Q3 2017 and held it in 7 quarters. The position peaked at $998K in Q3 2025. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Landscape Capital Management reported no remaining Biogen position as of Q1 2026 after selling out during the quarter.
  • Landscape Capital Management sold 2,459 Biogen shares in Q1 2026, an estimated $433K.
  • Landscape Capital Management first reported a position in Biogen in Q3 2017 and held it in 7 quarters.
  • Landscape Capital Management's Biogen position peaked at $998K in Q3 2025.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Landscape Capital Management's 13F filing for Q1 2026, filed 12 May 2026.